| Kristin Holzhauer, CCC-SLP, MA | |
|
176 Paulding Ave, Staten Island, NY 10314-3267 | |
| (917) 282-9952 | |
| Not Available |
| Full Name | Kristin Holzhauer |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 176 Paulding Ave, Staten Island, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013450261 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 025116-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristin Holzhauer, CCC-SLP, MA 176 Paulding Ave, Staten Island, NY 10314-3267 Ph: (917) 282-9952 | Kristin Holzhauer, CCC-SLP, MA 176 Paulding Ave, Staten Island, NY 10314-3267 Ph: (917) 282-9952 |
News Archive
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient's response to drug therapies used to treat infection with the hepatitis B virus
The GAVI Alliance on Thursday said an investigation conducted by a GAVI transparency and accountability team and auditors from the Malian government "has found that $563,000 was misused in two of its cash-based projects in Mali, and Malian authorities have agreed to pay it back," Reuters reports.
The Life Sciences Discovery Fund (LSDF) today announced nearly $1.5 million in Proof of Concept grants to Washington for-profit and non-profit organizations to foster translation of health-related technologies from idea to market launch.
The use of invasive procedures for treatment of ischemic heart disease has more than tripled in the past 2 decades and is likely to increase in high-risk patients, according to background information in the article.
Antibodies that target epidermal growth factor receptor (EGFR) have proven themselves as potent anticancer drugs. Now, a team of investigators led by Shuming Nie, Ph.D., and Lily Yang, Ph.D., both at the Emory University School of Medicine and members of the Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology, is aiming to capitalize on this targeting ability, using a modified anti-EGFR antibody to delivery nanoparticles into tumor cells.
› Verified 1 days ago
Mrs. Sharona Goldkrantz Rosenrauch, MS SLP CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 664 Stewart Ave, Staten Island, NY 10314 Phone: 718-982-5971 | |
Mrs. Rachel Ahmed, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 176 Bathgate Street, Staten Island, NY 10312 Phone: 917-861-6706 | |
Ms. Christine Ann Sprufero, CCC - SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-6521 | |
Ms. Nicole Lee Ambrose, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 South Avenue, Staten Island, NY 10314 Phone: 718-477-0961 Fax: 718-761-1643 | |
Ms. Kristina Sansone, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1060 Willowbrook Road, Ps 54 Charles W. Leng, Staten Island, NY 10314 Phone: 718-698-0600 Fax: 718-698-1736 | |
Miss Violetta Sukiasyan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 339 Montreal Ave, Staten Island, NY 10306 Phone: 917-378-4842 | |
Mrs. Alexis R Barbara, M.S., TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 493 Genesee Ave, Staten Island, NY 10312 Phone: 718-317-1414 |